Senior insider sale
Chief Medical Officer at VERICEL CORP — senior position signals high conviction
$724.6K
17.85K shares
What this filing means
HOPPER JONATHAN MARK plans to sell 17.85K shares of VERICEL CORP valued at approximately $724.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001959173-26-004921
Officer· Chief Medical Officer
Since Feb 2020
17.85K
Shares to sell
$724.6K
Approx. market value
10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/26/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/26/2026 | Stock Option Exercise Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.38K
Market value
$153.1K
6/2/2026
—Completed
Units to sell
3.47K
Market value
$121.5K
4/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$450.0K
6/26/2026
Total
Units
17.85K
Value
$724.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/2/2026 | 4.38K | $153.1K | — | Completed |
4/2/2026 | 3.47K | $121.5K | — | Completed |
| Planned — Approximate Date | ||||
6/26/2026 | 10K | $450.0K | NASDAQ | Planned |
| Total | 17.85K | $724.6K | ||